quinacrine has been researched along with Hypergonadotropic Hypogonadism in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, RO | 1 |
| Bühler, EM | 1 |
| Bühler, UK | 1 |
| Stalder, GR | 1 |
| Van den Berghe, H | 1 |
| Fryns, JP | 1 |
| David, G | 1 |
2 other studies available for quinacrine and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
[45,X/46,SYq dic-Sexchromosome mosaic].
Topics: Adult; Blood Cells; Cells, Cultured; Child; Female; Fibroblasts; Fluorescence; Hair; Humans; Hypogon | 1975 |
Renovascular hypertension. Prospective diagnostic yield in a random access population.
Topics: Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, 1-3; Fluorescence; Humans; Hypogon | 1973 |